To be clear, the FDA 510k clearances indicate two things:
1. That the products are safe
2. That they're similar enough to other products that supporting research or evidence doesn't need to be provided for assessment.
The approval process doesn't assess or validate the efficacy of the product or the quality of supporting evidence.
To make claims that a technology is substantially different in action or effectiveness would require a 'de novo' approval which is much harder and does require serious scrutiny of evidence and claims.
- Forums
- ASX - By Stock
- Ann: Next Science Investor Presentation May 2019
To be clear, the FDA 510k clearances indicate two things:1. That...
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $70.11M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 23.3¢ | $3.257K | 13.57K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6601 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 145820 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 17501 | 0.230 |
1 | 4545 | 0.220 |
1 | 25000 | 0.215 |
3 | 14448 | 0.205 |
1 | 20000 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 145820 | 2 |
0.295 | 3390 | 1 |
0.310 | 45789 | 1 |
0.330 | 180900 | 3 |
0.350 | 79920 | 3 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |